Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

Presentation TCT 2023

TCT 63: Cost-Effectiveness of Fractional Flow Reserve in Patients with Acute Myocardial Infarction and Multivessel Disease: Prespecified Analysis of FRAME-AMI Trial

Presenter: Seung Hun Lee

October 26, 2023

Presentation TCT 2023

TCT 623: Effects of Complete Revascularization in Relation to Left Ventricular Function in Patients with STEMI and Multivessel Disease: Data from the COMPLETE Randomized trial

Presenter: Denise Tiong

October 26, 2023

Presentation TCT 2023

TCT 357: Immediate Complete Revascularization in Patients Presenting With Acute Coronary Syndrome and Extensive Coronary Artery Disease: Insights From the BIOVASC Trial

Presenter: Hala Kakar

October 26, 2023

Presentation TCT 2023

TCT 462: Immediate Versus Staged Complete Revascularisation Angina-Related Quality of Life in patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease : Results From the Prospective, Open-Label, Non-Inferiority, Randomised…

Presenter: Paul Cummins

October 26, 2023

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

Impact of High Bleeding Risk status on comparative outcomes of Physiology-guided Complete versus Culprit-Only Revascularization in older MI patients: Data from the FIRE trial

Presenter: Simone Biscaglia

October 23, 2023

Advertisement

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

TCT 63: Cost-Effectiveness of Fractional Flow Reserve in Patients with Acute Myocardial Infarction and Multivessel Disease: Prespecified Analysis of FRAME-AMI Trial

TCT 623: Effects of Complete Revascularization in Relation to Left Ventricular Function in Patients with STEMI and Multivessel Disease: Data from the COMPLETE Randomized trial

TCT 357: Immediate Complete Revascularization in Patients Presenting With Acute Coronary Syndrome and Extensive Coronary Artery Disease: Insights From the BIOVASC Trial

TCT 462: Immediate Versus Staged Complete Revascularisation Angina-Related Quality of Life in patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease : Results From the Prospective, Open-Label, Non-Inferiority, Randomised…

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Impact of High Bleeding Risk status on comparative outcomes of Physiology-guided Complete versus Culprit-Only Revascularization in older MI patients: Data from the FIRE trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content